This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Zaph, C.
Right arrow Articles by Scott, P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Zaph, C.
Right arrow Articles by Scott, P.

 Previous Article  |  Next Article 

Infection and Immunity, March 2003, p. 1587-1589, Vol. 71, No. 3
0019-9567/03/$08.00+0     DOI: 10.1128/IAI.71.3.1587-1589.2003
Copyright © 2003, American Society for Microbiology. All Rights Reserved.

Interleukin-12 Regulates Chemokine Gene Expression during the Early Immune Response to Leishmania major

Colby Zaph and Phillip Scott*

Department of Pathobiology, School of Veterinary Medicine, University of Pennsylvania, Philadelphia, Pennsylvania 19104

Received 16 August 2002/ Returned for modification 12 November 2002/ Accepted 13 December 2002

Following infection with Leishmania major, the chemokines XCL1, CXCL10, and CCL2 were preferentially expressed in draining lymph nodes of resistant mice. Neutralization of interleukin 12 (IL-12) or gamma interferon in resistant mice resulted in decreased chemokine expression, while administration of IL-12 to susceptible mice resulted in an increase in the level of chemokine gene expression.


* Corresponding author. Mailing address: Department of Pathobiology, School of Veterinary Medicine, University of Pennsylvania, 3800 Spruce St., Philadelphia, PA 19104. Phone: (215) 898-1602. Fax: (215) 573-7023. E-mail: pscott{at}mail.vet.upenn.edu.

Editor: J. M. Mansfield


Infection and Immunity, March 2003, p. 1587-1589, Vol. 71, No. 3
0019-9567/03/$08.00+0     DOI: 10.1128/IAI.71.3.1587-1589.2003
Copyright © 2003, American Society for Microbiology. All Rights Reserved.




This article has been cited by other articles:

  • Sanabria, M. X. H., Vargas-Inchaustegui, D. A., Xin, L., Soong, L. (2008). Role of Natural Killer Cells in Modulating Dendritic Cell Responses to Leishmania amazonensis Infection. Infect. Immun. 76: 5100-5109 [Abstract] [Full Text]  
  • Strauss-Ayali, D., Conrad, S. M., Mosser, D. M. (2007). Monocyte subpopulations and their differentiation patterns during infection. J. Leukoc. Biol. 82: 244-252 [Abstract] [Full Text]  
  • Conrad, S. M., Strauss-Ayali, D., Field, A. E., Mack, M., Mosser, D. M. (2007). Leishmania-Derived Murine Monocyte Chemoattractant Protein 1 Enhances the Recruitment of a Restrictive Population of CC Chemokine Receptor 2-Positive Macrophages. Infect. Immun. 75: 653-665 [Abstract] [Full Text]  
  • Svensson, M., Zubairi, S., Maroof, A., Kazi, F., Taniguchi, M., Kaye, P. M. (2005). Invariant NKT Cells Are Essential for the Regulation of Hepatic CXCL10 Gene Expression during Leishmania donovani Infection. Infect. Immun. 73: 7541-7547 [Abstract] [Full Text]  
  • Steigerwald, M., Moll, H. (2005). Leishmania major Modulates Chemokine and Chemokine Receptor Expression by Dendritic Cells and Affects Their Migratory Capacity. Infect. Immun. 73: 2564-2567 [Abstract] [Full Text]  
  • Antoniazi, S., Price, H. P., Kropf, P., Freudenberg, M. A., Galanos, C., Smith, D. F., Muller, I. (2004). Chemokine Gene Expression in Toll-Like Receptor-Competent and -Deficient Mice Infected with Leishmania major. Infect. Immun. 72: 5168-5174 [Abstract] [Full Text]  
  • Del Rio, L., Butcher, B. A., Bennouna, S., Hieny, S., Sher, A., Denkers, E. Y. (2004). Toxoplasma gondii Triggers Myeloid Differentiation Factor 88-Dependent IL-12 and Chemokine Ligand 2 (Monocyte Chemoattractant Protein 1) Responses Using Distinct Parasite Molecules and Host Receptors. J. Immunol. 172: 6954-6960 [Abstract] [Full Text]